Case number 1:23-cv-00383
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 5, 2023 | 12 | CONSENT JUDGMENT AND ORDER OF PERMANENT INJUNCTION. Signed by Judge Gregory B. Williams on 7/5/23. (ntl) (Entered: 07/05/2023) (3) |
| Jul 5, 2023 | 13 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 07/05/2023) (4) |
| Jul 3, 2023 | 10 | Letter to The Honorable Gregory B. Williams from Steven J. Balick regarding the Parties' Proposed Consent Judgment and Injunction. (Balick, Steven) (Entered: 07/03/2023) (1) |
| Jul 3, 2023 | 11 | PROPOSED CONSENT JUDGMENT AND INJUNCTION, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Balick, Steven) (Entered: 07/03/2023) (3) |
| Jun 14, 2023 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Alembic to move against, answer or otherwise plead in response to the Complaint to July 5, 2023 filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/14/23. (ntl) (Entered: 06/14/2023) (0) |
| Jun 12, 2023 | 9 | STIPULATION TO EXTEND TIME for Alembic to move against, answer or otherwise plead in response to the Complaint to July 5, 2023 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gaza, Anne) (Entered: 06/12/2023) (2) |
| Apr 26, 2023 | 7 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For Alembic Pharmaceuticals Limited waiver sent on 4/13/2023, answer due 6/12/2023. (Balick, Steven) (Entered: 04/26/2023) (1) |
| Apr 26, 2023 | 8 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For Alembic Pharmaceuticals, Inc. waiver sent on 4/13/2023, answer due 6/12/2023. (Balick, Steven) (Entered: 04/26/2023) (1) |
| Apr 12, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:23-cv-00383-GBW, 1:23-cv-00389-GBW (rjb) (Entered: 04/12/2023) (0) |
| Apr 4, 2023 | 1 | COMPLAINT filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4105692.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(twk) (Entered: 04/05/2023) (Main Document) (12) |
| Apr 4, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 04/05/2023) (3) |
| Apr 4, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 24, 2023. Date of Expiration of Patent: October 31, 2026. Thirty Month Stay Deadline: August 24, 2025. (twk) (Entered: 04/05/2023) (2) |
| Apr 4, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,205,302. (twk) (Entered: 04/05/2023) (1) |
| Apr 4, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (twk) (Entered: 04/05/2023) (2) |
| Apr 4, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Nippon Shinyaku Co., Ltd. (twk) (Entered: 04/05/2023) (1) |
| Apr 4, 2023 | N/A | No Summons Issued. (twk) (Entered: 04/05/2023) (0) |
| Apr 4, 2023 | 1 | COMPLAINT filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4105692.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(twk) (Entered: 04/05/2023) (Exhibit A) (30) |
| Apr 4, 2023 | 1 | COMPLAINT filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4105692.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(twk) (Entered: 04/05/2023) (Civil Cover Sheet) (3) |
